Gallen Expert Consensus considered that the risk of breast cancer recurrence was mainly related to age, tumor size, histological grade, peritumor intravascular cancer emboli, and expression of the estrogen receptor (ER)/progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) (3). This evidence concerns the gene ERBB2 and breast cancer.